Frequency, risk factors and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment for hematological malignancies and nonmalignant diseases. Furthermore, haploidentical stem cell transplantation has been developed in the past two decades as another potential strategy for patients with no HLA-matched donor.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research